https://www.selleckchem.com/pr....oducts/pf-06650833.h
EG and are associated with adverse clinical outcomes. ANN NEUROL 2021;89872-883.A rapidly expanding catalog of neurogenetic disorders has encouraged a diagnostic shift towards early clinical whole exome sequencing (WES). Adult primary mitochondrial diseases (PMDs) frequently exhibit neurological manifestations that overlap with other nervous system disorders. However, mitochondrial DNA (mtDNA) is not routinely analyzed in standard clinical WES bioinformatic pipelines. We reanalyzed 11,424 exomes, enriched with neurological diseases,
Curtir
Comentario
Compartilhar
